What is Eikon Therapeutics, Inc. 's net investment in lease?

Eikon Therapeutics, Inc. (EIKN) reported net investment in lease of $91.07M in Q1 2026.

Eikon Therapeutics, Inc. EIKN Net Investment in Lease

BNL

Broadstone Net LeaseBNL

$14.39M+2,425%

PNC Financial ServicesPNC

$6.64B+6.6%

Delek Logistics PartnersDKL

$158.67M-16.4%

Wintrust FinancialWTFC

$362.77M+29.3%

1st Source CorporationSRCE

$6.96M-39.4%

WYF

WhiteFiber, Inc. Ordinary SharesWYFI

$3.9M—

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Market cap$521.35M—

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Eikon Therapeutics, Inc. 's net investment in lease?: Eikon Therapeutics, Inc. (EIKN) reported net investment in lease of $91.07M in Q1 2026.